We asked whether hydrogen sulfide (H2S), as the third gaseous mediator, provided fast antidepressant effect on major depressive disorders and underlying mechanisms.
Results:
The decreased level of H2S was detected in the hippocampus of chronic unpredictable mild stress (CUMS)-treated rats. Acute administration of H2S either by H2S inhalation or by the donor NaHS produced a rapid antidepressant-like behavioral effect. Further investigation demonstrated that this effect of H2S was mediated by reversing the CUMS-induced decrease in dendritic spine density and required the activation of mammalian target of rapamycin (mTOR)C1 and neurotrophic TrkB receptors, which proceeded to increase synaptic protein expression, including postsynaptic density protein 95, synaptophysin, and α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor GluR1/2 subunit.
Innovation:
This study provides the first direct evidence for detecting the decreased H2S in hippocampus of CUMS rats and the biological significance of H2S in treating major depression.
Conclusion:
Our data demonstrate that H2S activates mTORC1 signaling cascades and thereby produces fast-onset antidepressant effect. The study provides a profound insight into H2S or its donors as potent preventive and therapeutic agents for intervention of depression. Antioxid. Redox Signal. 27, 472–488.
Get full access to this article
View all access options for this article.
References
1.
AbeK and KimuraH. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci, 16: 1066–1071, 1996.
2.
AdachiM, BarrotM, AutryAE, TheobaldD, and MonteggiaLM. Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry, 63: 642–649, 2008.
ChenWL, XieB, ZhangC, XuKL, NiuYY, TangXQ, ZhangP, ZouW, HuB, and TianY. Antidepressant-like and anxiolytic-like effects of hydrogen sulfide in behavioral models of depression and anxiety. Behav Pharmacol, 24: 590–597, 2013.
5.
CorradettiMN and GuanKL. Upstream of the mammalian target of rapamycin: do all roads pass through mTOR?. Oncogene, 25: 6347–6360, 2006.
6.
DannonPN and GrunhausL. Effect of electroconvulsive therapy in repetitive transcranial magnetic stimulation non-responder MDD patients: a preliminary study. Int J Neuropsychopharmacol, 4: 265–268, 2001.
7.
DulawaSC, HolickKA, GundersenB, and HenR. Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology, 29: 1321–1330, 2004.
8.
DwivediY, RizaviHS, ConleyRR, RobertsRC, TammingaCA, and PandeyGN. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry, 60: 804–815, 2003.
9.
ElrodJW, CalvertJW, MorrisonJ, DoellerJE, KrausDW, TaoL, JiaoX, ScaliaR, KissL, SzaboC, KimuraH, ChowCW, and LeferDJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A, 104: 15560–15565, 2007.
10.
EtoK, AsadaT, ArimaK, MakifuchiT, and KimuraH. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun, 293: 1485–1488, 2002.
11.
FurneJ, SaeedA, and LevittMD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol, 295: R1479–R1485, 2008.
12.
HardinghamGE and BadingH. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci, 11: 682–696, 2010.
13.
HayN and SonenbergN. Upstream and downstream of mTOR. Genes Dev, 18: 1926–1945, 2004.
14.
HoefferCA and KlannE. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci, 33: 67–75, 2010.
15.
HoltRI, PhillipsDI, JamesonKA, CooperC, DennisonEM, and PevelerRC. The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study. J Affect Disord, 150: 84–90, 2013.
16.
HoshawBA, MalbergJE, and LuckiI. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res, 1037: 204–208, 2005.
17.
HuLF, LuM, TiongCX, DaweGS, HuG, and BianJS. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell, 9: 135–146, 2010.
18.
HuangCC, WeiIH, HuangCL, ChenKT, TsaiMH, TsaiP, TunR, HuangKH, ChangYC, LaneHY, and TsaiGE. Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biol Psychiatry, 74: 734–741, 2013.
19.
JiangJM, ZhouCF, GaoSL, TianY, WangCY, WangL, GuHF, and TangXQ. BDNF-TrkB pathway mediates neuroprotection of hydrogen sulfide against formaldehyde-induced toxicity to PC12 cells. PLoS One, 10: e0119478, 2015.
20.
KesslerRC, BerglundP, DemlerO, JinR, KoretzD, MerikangasKR, RushAJ, WaltersEE, and WangPS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289: 3095–3105, 2003.
21.
KimuraY, MikamiY, OsumiK, TsuganeM, OkaJI, and KimuraH. Polysulfides are possible H2S-derived signaling molecules in rat brain. FASEB J, 27: 2451–2457, 2013.
22.
KimuraY, ToyofukuY, KoikeS, ShibuyaN, NagaharaN, LeferD, OgasawaraY, and KimuraH. Identification of H2S3 and H2S produced by 3-mercaptopyruvate sulfurtransferase in the brain. Sci Rep, 5: 14774, 2015.
23.
KoponenE, RantamakiT, VoikarV, SaarelainenT, MacDonaldE, and CastrenE. Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol, 25: 973–980, 2005.
24.
KoponenE, VoikarV, RiekkiR, SaarelainenT, RauramaaT, RauvalaH, TairaT, and CastrenE. Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci, 26: 166–181, 2004.
25.
LiN, LeeB, LiuRJ, BanasrM, DwyerJM, IwataM, LiXY, AghajanianG, and DumanRS. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 329: 959–964, 2010.
26.
LiN, LiuRJ, DwyerJM, BanasrM, LeeB, SonH, LiXY, AghajanianG, and DumanRS. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry, 69: 754–761, 2011.
27.
LuoY, WuPF, ZhouJ, XiaoW, HeJG, GuanXL, ZhangJT, HuZL, WangF, and ChenJG. Aggravation of seizure—like events by hydrogen sulfide: involvement of multiple targets that control neuronal excitability. CNS Neurosci Ther, 20: 411–419, 2014.
28.
Machado-VieiraR, SalvadoreG, LuckenbaughDA, ManjiHK, and ZarateCJ. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry, 69: 946–958, 2008.
29.
MichelTM, PulschenD, and ThomeJ. The role of oxidative stress in depressive disorders. Curr Pharm Des, 18: 5890–5899, 2012.
30.
MiretM, Ayuso-MateosJL, Sanchez-MorenoJ, and VietaE. Depressive disorders and suicide: epidemiology, risk factors, and burden. Neurosci Biobehav Rev, 37: 2372–2374, 2013.
31.
MoneyKM, OlahZ, KoradeZ, GarbettKA, SheltonRC, and MirnicsK. An altered peripheral IL6 response in major depressive disorder. Neurobiol Dis, 89: 46–54, 2016.
32.
MonteggiaLM, BarrotM, PowellCM, BertonO, GalanisV, GemelliT, MeuthS, NagyA, GreeneRW, and NestlerEJ. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A, 101: 10827–10832, 2004.
33.
MurrayCJ and LopezAD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet, 349: 1498–1504, 1997.
34.
MusselmanDL, EvansDL, and NemeroffCB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry, 55: 580–592, 1998.
35.
NagyP, PalinkasZ, NagyA, BudaiB, TothI, and VasasA. Chemical aspects of hydrogen sulfide measurements in physiological samples. Biochim Biophys Acta, 1840: 876–891, 2014.
36.
OlsonKR. A practical look at the chemistry and biology of hydrogen sulfide. Antioxid Redox Signal, 17: 32–44, 2012.
37.
SchiavoneS and TrabaceL. Pharmacological targeting of redox regulation systems as new therapeutic approach for psychiatric disorders: a literature overview. Pharmacol Res, 107: 195–204, 2016.
38.
SchiavoneS, NeriM, MhillajE, MorgeseMG, CantatoreS, BoveM, RiezzoI, TucciP, PomaraC, TurillazziE, CuomoV, and TrabaceL. The NADPH oxidase NOX2 as a novel biomarker for suicidality: evidence from human post mortem brain samples. Transl Psychiatry, 6: e813, 2016.
39.
ShimadaS, FukaiM, WakayamaK, IshikawaT, KobayashiN, KimuraT, YamashitaK, KamiyamaT, ShimamuraT, TaketomiA, and TodoS. Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver. Surg Today, 45: 892–903, 2015.
40.
ShirayamaY, ChenAC, NakagawaS, RussellDS, and DumanRS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci, 22: 3251–3261, 2002.
41.
SuiL, WangJ, and LiBM. Role of the phosphoinositide 3–kinase-Akt-mammalian target of the rapamycin signaling pathway in long-term potentiation and trace fear conditioning memory in rat medial prefrontal cortex. Learn Mem, 15: 762–776, 2008.
42.
WangCM, YangYJ, ZhangJT, LiuJ, GuanXL, LiMX, LuHF, WuPF, ChenJG, and WangF. Regulation of emotional memory by hydrogen sulfide: role of GluN2B-containing NMDA receptor in the amygdala. J Neurochem, 132: 124–134, 2015.
43.
WeiWB, HuX, ZhuangXD, LiaoLZ, and LiWD. GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK/mTOR signal pathway in H9c2 cells. Mol Cell Biochem, 389: 249–256, 2014.
44.
WittchenHU, JacobiF, RehmJ, GustavssonA, SvenssonM, JonssonB, OlesenJ, AllgulanderC, AlonsoJ, FaravelliC, FratiglioniL, JennumP, LiebR, MaerckerA, van OsJ, PreisigM, Salvador-CarullaL, SimonR, and SteinhausenHC. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol, 21: 655–679, 2011.
45.
YangG, WuL, JiangB, YangW, QiJ, CaoK, MengQ, MustafaAK, MuW, ZhangS, SnyderSH, and WangR. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science, 322: 587–590, 2008.
46.
ZhangZ, HuangH, LiuP, TangC, and WangJ. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can J Physiol Pharmacol, 85: 1248–1253, 2007.
47.
ZhouX, AnG, and ChenJ. Hydrogen sulfide improves left ventricular function in smoking rats via regulation of apoptosis and autophagy. Apoptosis, 19: 998–1005, 2014.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
